Target intelligence / Profile preview

Ankyrin repeat domain 36 pseudogene 2 (ANKRD36P2)

Target
ANKRD36P2
Molecular classification
Pseudogene
01

Overview

ANKRD36P2 (Ankyrin repeat domain 36 pseudogene 2) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but is non-functional and does not encode a protein product[3][5]. It is related by sequence to the protein-coding ANKRD36 gene, but unlike ANKRD36, ANKRD36P2 does not produce a functional protein. There is no evidence that this pseudogene is involved in cellular signaling, disease pathways, or drug response. Because it is not a protein-coding gene and does not generate a functional molecular target, it is not considered for therapeutic targeting. No biological activities, disease associations, or pharmacological relevance have been attributed to ANKRD36P2 in scientific literature or genetic databases[3][5]. Additional Notes: Pseudogenes sometimes produce non-coding RNAs that can, in rare cases, regulate gene expression, but there is no published evidence indicating such a role for ANKRD36P2. No protein product, small molecule interaction, or biomarker application has been described for this locus[3][5]. If you intended to refer to the protein-coding gene ANKRD36, rather than its pseudogene, please specify, as the protein-coding gene has distinct properties and possible biological functions[1][4].

Beyond the preview

Go deeper on Ankyrin repeat domain 36 pseudogene 2 (ANKRD36P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 36 pseudogene 2 (ANKRD36P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call